54 reports

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Respiratory Disease
  • Europe
  • Japan
  • United States
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Infectious Disease
  • Pathology
  • Respiratory Disease
  • Europe
  • Demand
  • 3.3.1 DRIVERS AND OPPORTUNITIES
  • CHRONIC OBSTRUCTIVE PULMONARY DISEASE

TUBERCULOSIS (TB) INCIDENCE IS MUCH HIGHER IN BIG CITIES.

  • Respiratory Disease
  • World
  • Market Size
  • Medtronic, Inc.
  • ResMed Inc.

Tuberculosis, typhoid are examples of the bacterial diseases that are prevalent in many countries.

  • Respiratory Disease
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • ANTHONISEN NR (2005). LUNG HEALTH STUDY RESEARCH GROUP. ANN INTERN MED; 142(4): 233-239
  • PELAIA G, ET AL. (2012). THE POTENTIAL OF BIOLOGICS FOR THE TREATMENT OF ASTHMA. NATURE DRUG DISCOVERY; 11: 958-972

THE PULMONOLOGIST MAY ALSO ASK FOR A SKIN TEST TO DETERMINE THE PRESENCE OF TUBERCULOSIS.

  • Respiratory Disease
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

This accounts for one eight of global mortality count.

  • Respiratory Disease
  • World
  • Market Size
  • Astra Group
  • Becton Property Group
  • ASTHMA
  • GROWING INCIDENCE OF CHRONIC RESPIRATORY DISEASES

This device is mainly used for people with pulmonary tuberculosis, which is a highly infectious disease.

  • Respiratory Disease
  • World
  • Market Size
  • CareFusion Corporation
  • Teleflex Incorporated

CHEST X-RAY MAY SHOW ENLARGED LUNGS, IRREGULAR AIR POCKETS (BULLAE), OR A FLATTENED DIAPHRAGM, AND CAN HELP RULE OUT OTHER DISEASES, SUCH AS LUNG CANCER AND TUBERCULOSIS.

  • Respiratory Disease
  • Australia
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.

You can easily book an appointment with one online.

  • Respiratory Disease
  • World
  • Alere Inc.
  • CareFusion Corporation
  • Nihon Kohden Corporation

& nbsp; Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Respiratory Disease
  • Europe
  • Japan
  • United States
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Respiratory Disease
  • Europe
  • Japan
  • World
  • Demand
  • Market drivers

Tuberculosis (TB): In 2015, more than ## million people were diagnosed with TB, and around one million people died because of this disease.

  • Respiratory Disease
  • World
  • Demand
  • Forecast
  • Market Size

The most common diseases in the older adult population are respiratory tract infections, tuberculosis, COPD, and bronchial asthma.

  • Respiratory Disease
  • United States
  • World
  • Forecast
  • AirSep Corporation
  • 9.2.6 JAPAN

Egyptian Journal of Chest Diseases and Tuberculosis; ##: ##-## Reed CE (1999).

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG

You can easily book an appointment with one online.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • SOURCES NOT USED FOR COPD ANALYSES IN THE US, JAPAN, FIVE MAJOR EU MARKETS, AND CHINA
  • SOURCES NOT USED FOR COPD ANALYSES IN THE US, JAPAN, FIVE MAJOR EU MARKETS, AND CHINA

Furthermore, asthma and tuberculosis cases were excluded.

  • Respiratory Disease
  • European Union
  • Japan
  • North America
  • United States

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Infectious Disease
  • Pathology
  • Respiratory Disease
  • Europe
  • Demand
  • 6. COMPANY PROFILES

MOREOVER, IN INDIA, WE HAVE PARTNERED WITH THE GOVERNMENT OF INDIA TO CONDUCT CLINICAL TRIALS OF THE THERAPY IN PATIENTS WITH TUBERCULOSIS.

  • Respiratory Disease
  • North America
  • United States
  • AstraZeneca PLC
  • Novartis AG
  • 1.2 MARKET DEFINITION
  • NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)

Q. ##.

  • Respiratory Disease
  • Tuberculosis
  • North America
  • United States
  • Market Size
  • SMALL MOLECULE FOR COPD, CYSTIC FIBROSIS, PNEUMONIA AND PULMONARY TUBERCULOSIS - DRUG PROFILE
  • CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - PIPELINE BY MICROBION CORP, H1 2017

Chronic Obstructive Pulmonary Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease - Pipeline Review, H1 2017, provides an overview of the Chronic Obstructive Pulmonary Disease (Respiratory) pipeline landscape. Chronic...

  • Respiratory Disease
  • United States
  • Company
  • Product Initiative
  • AstraZeneca PLC
  • DRY POWDER DRUG DELIVERY SYSTEM - PRODUCT DESCRIPTION

Inhalers - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Inhalers - Medical Devices Pipeline Assessment, 2018" provides an overview of Inhalers currently in pipeline stage. The report provides comprehensive information on the pipeline products...

  • Respiratory Disease
  • United States
  • Company
  • Company Financials
  • Orion Corporation

Phase II data and orphan drug designation from FDA and EMA for non tuberculosis mycobacterium is expected in ##H 2017.

  • Respiratory Disease
  • Therapy
  • United States
  • World
  • Product Initiative

A growing number of infections such as pneumonia, tuberculosis, and gonorrhea are becoming difficult to treat, and the antibiotics used become less effective.

  • Respiratory Disease
  • Switzerland
  • World
  • Company
  • Polyphor Ltd.

Phase II data and orphan drug designation from FDA and EMA for non tuberculosis mycobacterium is expected in ##H 2017.

  • Respiratory Disease
  • Japan
  • United States
  • World
  • Product Initiative
  • AND IS EXPECTED TO MEASURE LUNG FUNCTION AS A PRIMARY ENDPOINT AND LUNG DENSITY AS A SECONDARY ENDPOINT.

SMALL MOLECULE FOR COPD, CYSTIC FIBROSIS, PNEUMONIA AND PULMONARY TUBERCULOSIS - DRUG PROFILE MICROBION CORP SMALL MOLECULE FOR COPD, CYSTIC FIBROSIS, PNEUMONIA AND PULMONARY TUBERCULOSIS SMALL MOLECULE IS UNDER DEVELOPMENT FOR TREATMENT OF PULMONARY TUBERCULOSIS, PNEUMONI

  • Respiratory Disease
  • United States
  • Company
  • Product Initiative
  • Galapagos NV

The prominent features of this report are - ##.

  • Cytokine
  • Respiratory Disease
  • World
  • Product Initiative
  • Pulmaquin group

These proteins are used for the treatment of various diseases such as asthma and COPD, diabetes, angina pectoris, cancer, bone disorders, migraine, and tuberculosis.

  • Respiratory Disease
  • North America
  • United States
  • Market Size
  • AstraZeneca PLC
  • ASTHMA - PIPELINE BY QU BIOLOGICS INC, H1 2018
  • ASTHMA - PIPELINE BY QURIENT CO LTD, H1 2018

In ultIMMa-## one patient receiving risankizumab presented with latent tuberculosis and was treated with rifampicin.

  • Research And Development
  • Respiratory Disease
  • United States
  • Company
  • AstraZeneca PLC

As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization' s three priority diseases - HIV/ AIDS, tuberculosis and malaria, the company has developed some of the leading global medicines in these fields.

  • Respiratory Device
  • Respiratory Disease
  • World
  • Forecast
  • AstraZeneca PLC
  • SMALL MOLECULE FOR COPD, CYSTIC FIBROSIS, PNEUMONIA AND PULMONARY TUBERCULOSIS - DRUG PROFILE
  • CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - PIPELINE BY MICROBION CORP, H2 2017

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2017, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) (Respiratory)...

  • Respiratory Disease
  • United States
  • Company
  • Product Initiative
  • AstraZeneca PLC